-
Innovation Ranking
NewInnovation Ranking – Alpha Networks Inc
Alpha Networks Inc (Alpha Networks), s subsidiary of Qisda Corp, is a technology company that manufacturer that designs, manufactures and markets network instruments and communications products. The company's product portfolio includes digital multimedia, LAN and MAN, mobile enterprise solutions, mobile and broadband and wireless, among others. Its mobile and broadband products comprise 5G routers, LTE routers, and small cell routers. Alpha Network’s LAN and MAN products include bare-metal switches, data center switches, enterprise switches, SMB switches, metro ethernet access switches,...
-
Innovation Ranking
NewInnovation Ranking – Alpha and Omega Semiconductor Limited
Alpha and Omega Semiconductor Limited (AOS) is engaged in the design, development and supply of power semiconductors. It offers power discrete products including low, medium, and high voltage power metal-oxide-semiconductor field-effect transistors (MOSFETs). The company's products are used in notebooks, desktop and tablet personal computers (PCs), servers, flat panel displays, televisions (TVs), graphics cards, game boxes, chargers, battery packs, power supplies, e-bikes, motor controls, smart phones, and networking equipment. The company has its operations in the US, China, Hong Kong,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Interferon Alpha in Warts
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Interferon Alpha in Warts report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Interferon Alpha in Warts Drug Details: Interferon alpha (IFN) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mitapivat Sulfate in Alpha Thalassaemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mitapivat Sulfate in Alpha Thalassaemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mitapivat Sulfate in Alpha Thalassaemia Drug Details: Mitapivat sulfate (Pyrukynd)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SLN-124 in Alpha Thalassaemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SLN-124 in Alpha Thalassaemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SLN-124 in Alpha Thalassaemia Drug Details: SLN-124 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GSK-5462688 in Alpha-1 Antitrypsin Deficiency (A1AD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GSK-5462688 in Alpha-1 Antitrypsin Deficiency (A1AD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GSK-5462688 in Alpha-1 Antitrypsin Deficiency (A1AD) Drug Details: GSK-5462688 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KB-408 in Alpha-1 Antitrypsin Deficiency (A1AD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KB-408 in Alpha-1 Antitrypsin Deficiency (A1AD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KB-408 in Alpha-1 Antitrypsin Deficiency (A1AD) Drug Details: KB-408 is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Biosimilar To Inhibit Interferon Alpha For Lupus Erythematosus in Lupus Erythematosus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Biosimilar To Inhibit Interferon Alpha For Lupus Erythematosus in Lupus Erythematosus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Biosimilar To Inhibit Interferon Alpha...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CONV 01-alpha in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CONV 01-alpha in Metastatic Castration-Resistant Prostate Cancer (mCRPC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CONV 01-alpha in Metastatic Castration-Resistant Prostate Cancer (mCRPC)...
-
Product Insights
Alpha Galactosidase A – Drugs In Development, 2023
Global Markets Direct’s Alpha Galactosidase A provides in depth analysis on Alpha Galactosidase A targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Alpha Galactosidase A targeted therapeutics...